AEON
AEON Biopharma, Inc.
NYSE MKT: AEON · HEALTHCARE · BIOTECHNOLOGY
$0.95
-3.02% today
Updated 2026-04-29
Market cap
$24.16M
P/E ratio
—
P/S ratio
97.16x
EPS (TTM)
$-3.95
Dividend yield
—
52W range
$0 – $1
Volume
0.1M
AEON Biopharma, Inc. (AEON) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
0.00%
ROA
-234.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $3.36M | $172.92M | 99.97% | -1,607.57% | 5,151.03% |
| 2020 | $2.52M | $-32.91M | 100.00% | -650.83% | -1,307.11% |
| 2021 | $0.00 | $-55.64M | — | — | — |
| 2022 | $0.00 | $-52.56M | — | — | — |
| 2023 | — | $-384.63M | — | — | — |
| 2024 | $0.00 | $42.01M | — | — | — |
| 2025 | $0.00 | $-39.22M | — | — | — |